When a child develops Stevens-Johnson syndrome (SJS), the earliest warning signs often look like something far less serious. Fever, sore throat, irritated eyes, and other flu-like symptoms may appear days before the severe skin reaction associated with the condition becomes obvious.
The similarity to childhood illnesses can make pediatric SJS particularly difficult to recognize. Recent research on children with SJS and toxic epidermal necrolysis (TEN) highlights the role medications play in many pediatric cases while emphasizing the need for greater awareness among caregivers and healthcare providers.
Why Pediatric SJS Can Be Difficult to Recognize
Stevens-Johnson syndrome in children, like adults, rarely begins with severe skin symptoms. Instead, SJS typically begins with fever, fatigue, sore throat, cough, body aches, and eye irritation. The symptoms may appear days before a rash develops. By the time blistering or skin peeling becomes obvious, the reaction may already be progressing rapidly.
Recognizing the early warning signs can be especially difficult in younger children, who may struggle to explain what they’re experiencing. Rather than describing skin pain, burning eyes, or painful mouth sores, a child may simply seem irritable, refuse food or drinks, cry when swallowing, or appear unusually tired. Because the symptoms can resemble viral infections, strep throat, conjunctivitis, and other common illnesses, SJS is not always immediately suspected.
This is one reason caregivers play such an important role. Parents are often the first to notice symptoms developing shortly after a new medication is started or when a child's condition appears unusually severe. Providing healthcare providers with a complete medication history, including when a drug was started and when symptoms first appeared, may help physicians determine whether a serious drug reaction is occurring.
Many pediatric SJS cases develop within the first several weeks after a new medication is introduced. Commonly reported triggers include certain antibiotics, anticonvulsants, and nonsteroidal anti-inflammatory drugs (NSAIDs), although infections can also contribute to some cases.
What Happens Once SJS Is Suspected
Unlike many childhood illnesses that improve with time, Stevens-Johnson syndrome can worsen quickly. For caregivers, one of the most important steps is recognizing that unusual symptoms after a new medication should never be ignored.
Once SJS is suspected, identifying and discontinuing the potential trigger becomes a critical part of treatment. Children frequently require hospitalization, and severe cases may require treatment in intensive care units or specialized burn centers.
SJS can also affect the eyes, mouth, respiratory system, and other organs. Even after it resolves, some children experience lasting complications involving vision, skin pigmentation, respiratory function, chronic pain, or recurring eye irritation and dryness. Ocular injuries are among the most concerning long-term effects, as severe cases can lead to corneal scarring, damage to the eye's surface, and permanent vision impairment.
Research suggests that long-term complications are relatively common among pediatric SJS/TEN survivors, with some studies finding that nearly half develop lasting health issues after recovery. While some children recover without significant long-term disability, others may require years of follow-up care from ophthalmologists, dermatologists, pulmonologists, and other specialists to manage complications that affect their quality of life.
When Families Begin Asking Legal Questions
After a child is diagnosed with SJS, families are often focused on immediate medical care. However, as recovery progresses, questions frequently arise about what caused the reaction and whether it could have been prevented.
Attorneys who represent Stevens-Johnson syndrome survivors often see how difficult a delayed diagnosis can be for families. According to Ashley Spires of Childers, Schlueter & Smith, a firm that focuses on SJS litigation nationwide, many parents are left searching for answers after the immediate medical crisis has passed.
"Families can spend weeks or months focused entirely on helping their child recover from SJS," Spires said. "Later, they begin asking what caused the reaction, did a medication have known risks, and if there were warning signs that could have led to earlier intervention."
In medication-related SJS cases, parents may also question whether physicians had enough information to identify the reaction sooner or if a drug manufacturer properly disclosed known safety concerns. These cases often require extensive review of medical records, prescription histories, regulatory documents, and scientific literature to determine what information was available when the medication was prescribed.
Not every case of pediatric SJS results in a lawsuit. Some may be linked to infections rather than medications, and every situation involves unique medical circumstances.
For many families, the most difficult questions arise after the immediate medical emergency has passed. Understanding what triggered the reaction, whether warning signs were missed, and what long-term care may be necessary often becomes an important part of the recovery process. While pediatric Stevens-Johnson syndrome remains rare, its potential impact can extend far beyond the initial hospitalization.
